Biologic Cost per Effectively Treated Rheumatoid Arthritis Patient in a Large Managed Care Population: A Retrospective Cohort Study
**Background:** Until recently, the lack of clinical outcomes information for rheumatoid arthritis (RA) in administrative claims databases limited their use in comparative effectiveness research. A validated claims-based algorithm has been developed to estimate the effectiveness of biologics for RA,...
Saved in:
Main Authors: | Tao Gu, Neel Shah, Gaurav Deshpande, Derek H. Tang, Debra F. Eisenberg, David J. Harrison |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2015-09-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9830 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Distinguishing rheumatoid arthritis from psoriatic arthritis
by: Joseph F Merola, et al.
Published: (2018-08-01) -
A Comprehensive Dataset on Microbiome Dynamics in Rheumatoid Arthritis from a Large-Scale Cohort Study
by: Jing Li, et al.
Published: (2025-02-01) -
Targeted Therapy for Rheumatoid Arthritis in the New Era
by: WANG Jun, et al.
Published: (2025-01-01) -
Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
by: Xavier Mariette, et al.
Published: (2022-02-01) -
Clinical and Immunological Characteristics of Elderly Onset Rheumatoid Arthritis
by: LI Zhengfang, et al.
Published: (2025-01-01)